Synapse February 2013 focuses on injunctions against pharma patent infringement

In Synapse February 2013, Taylor Wessing discusses the issue of interim injunctions against pharmaceutical patent infringement. Synapse focuses on law for the life sciences industry.

The patent system gives innovators a monopoly right — a right that in the life science and pharmaceutical sector can be extremely valuable. It is perhaps unsurprising therefore that a manufacturer will go to some lengths to enforce their patent rights protecting a product.

A powerful tool for this purpose is the injunction, which — if deployed correctly — can stop a potential infringer in their tracks.

Other topics covered in Synapse February 2013 include: the Transparency Directive and the customs regulation.

To read more click here.

  • Print

Briefings from Taylor Wessing

View more briefings from Taylor Wessing

Analysis from The Lawyer

  • merger deal

    Corporate crunch time: who will triumph at The Lawyer Awards 2014?

    As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014. 

  • singapore orchid

    Singapore: Cash course

    The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world

View more analysis from The Lawyer

Overview

5 New Street Square
London
EC4A 3TW
UK
http://www.taylorwessing.com

Turnover (£m): 228.00
No. of lawyers: 860
Jurisdiction: UK
No. of offices: 4
No. of qualified lawyers: 67 (International 50)

Jobs